stockportfolio.pro
Stocks / DGX vs LH
DGX vs LH
Quest Diagnostics Incorporated and Labcorp Holdings Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Quest Diagnostics Incorporated (DGX) | Labcorp Holdings Inc. (LH) | |
|---|---|---|
| Market cap | $22.6B | $22.2B |
| Revenue (latest FY) | $11.04B | $13.95B |
| Net income (latest FY) | $992.00M | $876.50M |
| Revenue growth (5y CAGR) | 3.2% | -0.0% |
| Net margin | 9.0% | 6.3% |
| Return on equity | 13.8% | 10.2% |
| P/E ratio | 22.6 | 24.0 |
| Dividend yield | 1.7% | 1.1% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open DGX — free Open LH — freeFrequently asked questions
Which is bigger, DGX or LH?
Quest Diagnostics Incorporated is larger by market capitalization — $22.6B versus $22.2B.
Which grows faster, DGX or LH?
Over the last five fiscal years, Quest Diagnostics Incorporated grew revenue faster — 3.2%/yr versus -0.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.